Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial

• DOI: 10.1039/c9fo01583c
• Publication Date: 2019-11-19T02:23:34Z
• Authors: Song Lin; Shanliang Zhao; Jiahong Liu; Jianwen Zhang; Chao Zhang; Haibo Hao; Yuxia Sun; Jing Cai; Yang Yang; Yan Ma; Yuanyuan Li; Jinyu Wang; Aiguo Ma
• Keywords: Lactobacillus casei; Open label

Anti-tuberculosis (TB) drugs can induce a series of gastrointestinal adverse events, which seriously affect patients’ quality life and may lead to treatment failure.